Consensus guidelines for glycemic monitoring in type 1/type 2 &amp; GDM

Kesavadev, Jothydev; Sadikot, S.M.; Wangnoo, Subhash Kumar; Kannampilly, Johnny; Saboo, Banshi; Aravind, SR; Kalra, Sanjay; Makkar, Brij; Maji, D; Saikia, Mihir; Anjana, R M; Rajput, Rajesh; Singh, S.K.; Shah, Sanjiv J.; Dhruv, Urman; Vishwanathan, Vijay

doi:10.1016/j.dsx.2014.04.030

Cited by 9 publications

(10 citation statements)

References 62 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There have been a few guidelines available both internationally as well as specific to the Indian scenario, regarding the use of various diabetes technologies. [ 698 723 724 725 726 727 728 729 730 731 732 ] The current RSSDI guidelines are aimed at preventive technologies which are directed at saving the cost and future complications. Most of the technologies discussed are those which can be used by any modern medicine physician with appropriate training.…”

Section: B Ackgroundmentioning

confidence: 99%

“…SMBG with a quality glucose meter has been proven to be useful at any stage of diabetes provided a structured SMBG protocol is implemented with patient centred approach. Glucose monitoring, particularly SMBG is considered as an integral part of diabetes care[ 698 726 733 734 ] since achieving optimal glycaemic control has been proven to be associated with reductions in both macro-and microvascular complications of the disease. [ 169 295 735 ] SMBG has been demonstrated to be helpful or to correlate with effective management in both insulin-treated and noninsulin-treated diabetes.…”

Section: R Ationale and E Videncementioning

confidence: 99%

See 1 more Smart Citation

RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020

Chawla

Madhu

Makkar

et al. 2020

Indian J Endocr Metab

Self Cite

111

View full text Add to dashboard Cite

Section: B Ackgroundmentioning

confidence: 99%

Section: R Ationale and E Videncementioning

confidence: 99%

RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020

Chawla

Madhu

Makkar

et al. 2020

Indian J Endocr Metab

Self Cite

111

View full text Add to dashboard Cite

“…The use of blood glucose monitoring by PwDs being treated with insulin has been demonstrated to reduce HbA 1c and the occurrence and costs of the associated comorbidities and is considered the standard of care for these patients [92,124,125]. Blood glucose monitoring for patients being treated only with oral medications can, in fact, facilitate long-term improvement in glycemic status, but only when the following conditions are met: The SMBG regimen is structured (both in timing and frequency) to obtain actionable information about each patient's glucose control.…”

Section: Payer Requirementsmentioning

confidence: 99%

Electrochemical Glucose Biosensors for Diabetes Care

Ocvirk¹,

Buck²,

DuVall³

2016

Trends in Bioelectroanalysis

View full text Add to dashboard Cite

Blood glucose monitoring (BGM) is the most successful application of electrochemical biosensor technology and has motivated tremendous improvements in biology, chemistry, measurement, and fabrication methods of biosensors. The performance of electrochemical biosensors used for BGM has improved greatly over the last four decades. Technological advance has allowed to measure blood glucose (BG) over a wide range of glucose concentration, a wide temperature and hematocrit range in the presence of an abundance of interfering substances with ever-increasing accuracy, and precision in minute sample volumes. The use of optimized enzymes, mediators, and electrochemical measurement methods enables this tremendous progress in performance. Continuous glucose monitoring (CGM) systems based on minimally invasive amperometric sensors, inserted into the subcutaneous tissue, have significantly improved over initial offerings over the last 15 years with regard to time of use, accuracy, reliability, and convenience due to a multitude of parallel advances: materials needed for enzyme immobilization, polymeric cover membranes, and biocompatible coatings needed to tackle the response by the complex body interface have been developed; wireless transfer and processing of unprecedented data volume have been established; effortless and painless insertion schemes of ever smaller sensors have been realized in order to overcome the concerns of persons with diabetes (PwDs) to use a minimally invasive sensor; and scalable manufacturing technologies of miniaturized minimally invasive sensors have allowed for ever improved reproducibility and increased production volume. Looking ahead, the demands on blood glucose system performance G. Ocvirk (*) Roche Diabetes Care GmbH, Mannheim, Germany e-mail: gregor.ocvirk@roche.com H. Buck and S.H. DuVall Roche Diabetes Care, Inc., Indianapolis, IN, USA e-mail: harvey.buck@roche.com; stacy.duvall@roche.com are expected to grow even as the pressures to lower the cost of systems increase. The drive for the future is to continue to push the limits on system performance under real-life conditions while lowering cost, all while finding ways to provide the best medical value to PwDs and healthcare providers. Technical issues of commercially available CGM sensors remain to be solved which currently impede reliable hypo-and hyperglycemic alarms, safe insulin dosing recommendations, or insulin pump control at any time of use. It is realistic to assume that continuous glucose monitoring (CGM) systems will be adopted in the future by a larger population of PwDs. Yet it is also clear that BGM systems will remain a major choice of the great majority of PwDs on a global scale. This review offers a technical overview about user, system, and major regulatory requirements and available suitable sensor technology and demonstrated performance of electrochemical BGM and CGM systems from an industrial R&D perspective.

show abstract

“…Fructosamine test is another tool, which denotes the blood glucose levels over the past 2 to 3 weeks. Another such tool is continuous glucose monitoring (CGM), which measures interstitial fluid glucose levels continuously for varying duration of time [21][22][23][24].…”

Section: Introductionmentioning

confidence: 99%

RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India

P¹,

Makkar

Kumar

et al. 2018

Int J Diabetes Dev Ctries

Self Cite

View full text Add to dashboard Cite

Maintaining a good glycemic control is crucial in the management of diabetes mellitus (DM) as it is associated with the reduction in both macro and microvascular complications of the disease. Self-monitoring of blood glucose (SMBG), which provides the day-today blood glucose levels, is a simple and practical tool for maintaining a good glycemic control. Although SMBG is widely practiced in other countries, its use in India is very limited. Even when used, it is not carried out is a structured manner. There seems to be a lack of education about the purpose of SMBG and the correct process and schedule to be followed. This highlights the unmet need for country-specific SMBG recommendations. In order to fulfil this need, a panel of expert endocrinologists/ diabetologists came together under the aegis of Research Society for the Study of Diabetes in India (RSSDI). They reviewed the current literature, combined the evidences with their clinical knowledge and expertise, and developed consensus recommendations for SMBG practice in India. This document provides a comprehensive review of the current literature on SMBG and presents the recommendations made by the expert panel.

show abstract

Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM

Cited by 9 publications

References 62 publications

RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020

RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020

Electrochemical Glucose Biosensors for Diabetes Care

RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India

Contact Info

Product

Resources

About